Skip to main content
Fig. 5 | Stem Cell Research & Therapy

Fig. 5

From: The safety and effectiveness of genetically corrected iPSCs derived from β-thalassaemia patients in nonmyeloablative β-thalassaemic mice

Fig. 5

Haematopoietic differentiation of β-thalassaemia-iPSCs and genetically corrected iPSCs in BM after transplantation. a Flow cytometry analysis of human CD45 and CD71 in BM from the five groups of mice transplanted with (right panel)/without (left panel) α-MEM, UCBCs, hESCs, niPSCs, piPSCs or ciPSCs. b Flow cytometry analyses of human CD3, CD31, CD34, CD43, CD45, CD71 and CD235a in BM cells

Back to article page